Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments.

Harry Travis, BS Pharm, MBA, explores how artificial intelligence (AI) can revolutionize pharmacy workflows for sustainable productivity gains.

“Utilizing real-world data, technology, strategic solutions, and cross-departmental partnerships will help ensure equitable access, so the right member receives the right drug at the right time and ...

Tunstall: Medicaid cuts in HR 1 are likely to have an immediate impact. According to government estimates, these cuts could result in 17 million Americans losing their health coverage. Medicaid is a ...

By emphasizing analytical studies instead of routine clinical trials, the FDA signals its intent to reduce the cost (often estimated at $100 million to $300 million) and time (typically 6–9 years) ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A ...

Brigid Groves, PharmD, MS, discusses the importance of using trustworthy sources so that pharmacists can support communities ...

It is necessary to balance rigorous clinical trials with real-world evidence (RWE) to show how data from everyday practice ...

ACA marketplace premiums are projected to rise by 26% in 2026, with potential further increases if premium tax credits expire ...

Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies ...

B/F/TAF shows lower ART switching rates and higher persistence among HIV patients, especially those with mental health or ...